COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
Virginia Meca‐Lallana, Clara Aguirre, Beatrizdel Río, Laura Cardeñoso, Teresa Alarcón, José Vivancos
Topics & Concepts
MedicineMultiple sclerosisCoronavirus disease 2019 (COVID-19)OcrelizumabSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyDermatologyRituximabInternal medicineImmunologyAntibodyDiseaseInfectious disease (medical specialty)OutbreakMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSARS-CoV-2 and COVID-19 Research